832 related articles for article (PubMed ID: 30843891)
21. Long-Term Follow-Up of Node-Negative Breast Cancer Patients Evaluated via Sentinel Node Biopsy After Neoadjuvant Chemotherapy.
Nogi H; Uchida K; Mimoto R; Kamio M; Shioya H; Toriumi Y; Suzuki M; Nagasaki E; Kobayashi T; Takeyama H
Clin Breast Cancer; 2017 Dec; 17(8):644-649. PubMed ID: 28601382
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
[TBL] [Abstract][Full Text] [Related]
23. Axillary dissection in sentinel lymph node positive breast cancer: Is the staging information worthwhile for patients?
Chang DW; Bressel M; Hansen C; Blinman P; Schofield P; Chua BH
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e27-e34. PubMed ID: 31461222
[TBL] [Abstract][Full Text] [Related]
24. Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure.
Derkx F; Maaskant-Braat AJ; van der Sangen MJ; Nieuwenhuijzen GA; van de Poll-Franse LV; Roumen RM; Voogd AC
Eur J Surg Oncol; 2010 Jul; 36(7):646-51. PubMed ID: 20537838
[TBL] [Abstract][Full Text] [Related]
25. Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature.
Banys-Paluchowski M; Gruber IV; Hartkopf A; Paluchowski P; Krawczyk N; Marx M; Brucker S; Hahn M
Arch Gynecol Obstet; 2020 Feb; 301(2):341-353. PubMed ID: 31897672
[TBL] [Abstract][Full Text] [Related]
26. Can we define a role for perisentinel lymph-nodes on breast cancer disease?
Sianesi M; Del Rio P; Martella E; De Notarpietro F; De Simone B; Ghirarduzzi A; Sianesi N; Arcuri MF
Ann Ital Chir; 2011; 82(3):173-7. PubMed ID: 21780557
[TBL] [Abstract][Full Text] [Related]
27. The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT).
Peppe A; Wilson R; Pope R; Downey K; Rusby J
Breast; 2017 Oct; 35():104-108. PubMed ID: 28704697
[TBL] [Abstract][Full Text] [Related]
28. Does Conservative Surgery for Breast Carcinoma Still Require Axillary Lymph Node Evaluation? A Retrospective Analysis of 1156 Consecutive Women With Early Breast Cancer.
Marrazzo A; Damiano G; Taormina P; Buscemi S; Lo Monte AI; Marrazzo E
Clin Breast Cancer; 2017 Apr; 17(2):e53-e57. PubMed ID: 27840075
[TBL] [Abstract][Full Text] [Related]
29. The need for lymph node dissection in nonmetastatic breast cancer.
Pesce C; Morrow M
Annu Rev Med; 2013; 64():119-29. PubMed ID: 23020881
[TBL] [Abstract][Full Text] [Related]
30. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection.
van Rijk MC; Nieweg OE; Rutgers EJ; Oldenburg HS; Olmos RV; Hoefnagel CA; Kroon BB
Ann Surg Oncol; 2006 Apr; 13(4):475-9. PubMed ID: 16485148
[TBL] [Abstract][Full Text] [Related]
31. Imaging axillary lymph nodes in patients with newly diagnosed breast cancer.
Rahbar H; Partridge SC; Javid SH; Lehman CD
Curr Probl Diagn Radiol; 2012; 41(5):149-58. PubMed ID: 22818835
[TBL] [Abstract][Full Text] [Related]
32. Conservative Management of Positive Axilla After Neoadjuvant Systemic Therapy-The Need for, and Review of, Techniques Used for Lymph Node Localization.
Green M; Neamonitou F; Vidya R
Clin Breast Cancer; 2018 Oct; 18(5):e739-e742. PubMed ID: 29983380
[TBL] [Abstract][Full Text] [Related]
33. De-escalation of axillary surgery in patients outside Z0011 criteria.
Giannakou A; Gooch J; Gergelis KR; Weiss A
Surgery; 2023 Aug; 174(2):416-418. PubMed ID: 37156648
[TBL] [Abstract][Full Text] [Related]
34. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB
J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295
[TBL] [Abstract][Full Text] [Related]
35. Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt.
Dominici LS; Sineshaw HM; Jemal A; Lin CC; King TA; Freedman RA
Breast Cancer Res Treat; 2018 Jan; 167(2):555-566. PubMed ID: 28990127
[TBL] [Abstract][Full Text] [Related]
36. FDG-PET for axillary lymph node staging in primary breast cancer.
Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
[TBL] [Abstract][Full Text] [Related]
37. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
38. Axillary staging prior to neoadjuvant chemotherapy: the roles of sentinel lymph node biopsy and axillary ultrasonography.
Lee MC; Joh JE; Chau A
Cancer Control; 2012 Oct; 19(4):277-85. PubMed ID: 23037495
[TBL] [Abstract][Full Text] [Related]
39. Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?
Rosenberger LH; Ren Y; Thomas SM; Greenup RA; Fayanju OM; Hwang ES; Plichta JK
Breast Cancer Res Treat; 2020 Feb; 179(3):661-670. PubMed ID: 31741179
[TBL] [Abstract][Full Text] [Related]
40. Initial axillary staging of breast cancer using ultrasound-guided fine needle aspiration: a liquid-based cytology study.
Schiettecatte A; Bourgain C; Breucq C; Buls N; De Wilde V; de Mey J
Cytopathology; 2011 Feb; 22(1):30-5. PubMed ID: 20337693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
